| # | Drug | Count |
|---|---|---|
| 0 | NEMOLIZUMAB-ILTO | 30 |
| 1 | TERIPARATIDE | 29 |
| 2 | DIAZEPAM | 19 |
| 3 | ETANERCEPT | 17 |
| 4 | ABALOPARATIDE | 16 |
| 5 | DIAZEPAM ORAL | 16 |
| 6 | DIAZEPAM ORAL SOLUTION (CONCENTRATE) | 16 |
| 7 | METFORMIN | 16 |
| 8 | METFORMIN ER 500 MG | 16 |
| 9 | METFORMIN ER 750 MG | 16 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BUPRENORPHINE HCL | 3 | 0.0034 |
| 1 | SODIUM MONOFLUOROPHOSPHATE | 1 | 0.0027 |
| 2 | NEMOLIZUMAB-ILTO | 30 | 0.0019 |
| 3 | CETRORELIX ACETATE | 1 | 0.0016 |
| 4 | ACETAMINOPHEN AND CODEINE PHOSPHATE | 2 | 0.0011 |
| 5 | METHAMPHETAMINE HYDROCHLORIDE | 1 | 0.0009 |
| 6 | MEPROBAMATE | 1 | 0.0008 |
| 7 | NATEGLINIDE | 1 | 0.0007 |
| 8 | PSYLLIUM HUSK | 1 | 0.0007 |
| 9 | INTERFERON GAMMA-1B | 1 | 0.0007 |
| # | Drug class | Count |
|---|---|---|
| 0 | GLP-1 Receptor Agonist [EPC] | 32 |
| 1 | Interleukin-31 Receptor alpha Antagonist [EPC] | 30 |
| 2 | Parathyroid Hormone Analog [EPC] | 29 |
| 3 | Benzodiazepine [EPC] | 22 |
| 4 | Tumor Necrosis Factor Blocker [EPC] | 19 |
| 5 | Insulin Analog [EPC] | 17 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 16 |
| 7 | Parathyroid Hormone-Related Peptide Analog [EPC] | 16 |
| 8 | Corticosteroid [EPC] | 12 |
| 9 | Androgen [EPC] | 11 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 4 | 0.0058 |
| 1 | Interleukin-31 Receptor alpha Antagonist [EPC] | 30 | 0.0019 |
| 2 | Adrenocorticotropic Hormone [EPC] | 1 | 0.0011 |
| 3 | Interferon gamma [EPC] | 1 | 0.0007 |
| 4 | Parathyroid Hormone-Related Peptide Analog [EPC] | 16 | 0.0005 |
| 5 | Androgen [EPC] | 11 | 0.0004 |
| 6 | Provitamin D2 Compound [EPC] | 8 | 0.0003 |
| 7 | Parathyroid Hormone Analog [EPC] | 29 | 0.0003 |
| 8 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 8 | 0.0002 |
| 9 | Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] | 5 | 0.0002 |